Austin, TX – 16 January 2025 – The Clinical Data Interchange Standards Consortium (CDISC) is proud to announce its new Chair, Chair-Elect, and Board Members. These accomplished leaders bring diverse expertise and a shared commitment to advancing global data standards, furthering CDISC’s vision to amplify data’s impact to advance research and improve global health.
Joining the CDISC Board of Directors are Catherine Chronaki and Patrick Nadolny, whose deep experience in clinical data and healthcare innovation will bring valuable perspectives to the organization. Current CDISC Board Members Brooke Hinkson and Jonathan Chainey have been named Board Chair and Chair-Elect, respectively.
New Board Members
Catherine Chronaki is Secretary General at the HL7 Europe Foundation and served as the President of the European Federation for Medical Informatics (EFMI) from 2020 through 2022. A computer engineer by training, Chronaki has engaged in eHealth projects since the early 1990s. Her work has focused on designing, implementing, and evaluating health information infrastructures, employing interoperability standards, and extending electronic health records (EHRs) to support disease surveillance and emergency management. Her extensive contributions to eHealth projects have been instrumental in advancing healthcare innovation in Europe and beyond.
Patrick Nadolny, Global Head of Clinical Data Management at Sanofi, brings over 30 years of experience across pharmaceuticals, medical devices, and biologics. A member of the Executive Board of Directors for the Society for Clinical Data Management (SCDM) and its Chair in 2024, Nadolny led the SCDM Innovation Committee, driving the transformation of clinical data management into clinical data science. His expertise in strategic planning, technology innovation, and change management continues to shape the future of the field of Clinical Data Science.
New Board Chair and Chair-Elect
Brooke Hinkson, Executive Director of Global Clinical Data Standards at Merck, has over 30 years of clinical research experience across CROs, healthcare providers, technology vendors, and biopharmaceutical companies. A member of the CDISC Board since 2022. Hinkson has been instrumental in defining clinical data standards strategies and operating models to support the adoption, governance, and use of standards. Passionate about leveraging data as a strategic asset, she is committed to accelerating the delivery of therapies to patients through standards and innovation.
Jonathan Chainey is Executive Director and Global Head of Data Standards & Governance within Data Science & Analytics, Product Development at Roche. With over 25 years of biopharma industry experience, he leads a global team accountable for the cross-functional governance and adoption of Roche’s CDISC-aligned global data standards across early- and late-phase clinical trials. A member of the CDISC Board since 2023, Chainey previously served as Chair of the CDISC Advisory Council. He is passionate about realizing the vision of protocol-driven, data-standards enabled automation and bridging the domains of clinical care and research in order to improve outcomes for patients.
“We are entering a pivotal era for CDISC,” said Brooke Hinkson, incoming Board Chair. “I am honored to lead the Board as we continue advancing global data standards that drive innovation, collaboration, and better outcomes for patients. With this exceptional leadership team, I am excited for what lies ahead.”
CDISC CEO Chris Decker also shared his enthusiasm, "We are thrilled to welcome Catherine and Patrick to the Board and to congratulate Brooke and Jonathan on their new leadership roles. Their expertise and passion for advancing data standards will be invaluable as CDISC continues to drive progress toward making data more accessible, interoperable, and reusable, enabling more meaningful and effective research."
The CDISC Board of Directors also includes the following continuing members: Wenjun Bao, Karen Curran, David Hardison, Erik Pulkstenis, Lisa Lin, Rhona O'Donnell, Mihoko Okada, and Christina Reith.
About CDISC
Clinical Data Interchange Standards Consortium (CDISC) creates clarity in clinical research by convening a global community to develop and advance data standards of the highest quality. Required by the United States Food and Drug Administration (FDA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the European Medicines Agency (EMA) and China National Medical Products Administration (NMPA) and adopted by the world’s leading research organizations, CDISC standards enable the accessibility, interoperability, and reusability of data. With the help of CDISC standards, the entire research community can maximize the value of data for more efficient and meaningful research that has invaluable impact on global health. CDISC is a 501(c)3 global nonprofit charitable organization with thousands of partners, volunteers, and member organizations around the world.
